CAN DO FOR YOU

UT RECHT – MONDAY, OCTOBER 11
BRUSSELS – TUESDAY, OCTOBER 12
FRANKFURT – THURSDAY, OCTOBER 14
BASEL – FRIDAY, OCTOBER 15
LEARN WHAT WATERS
LATEST INNOVATIVE MS TECHNOLOGIES
CAN DO FOR YOU
Waters is proud to invite you to an open Waters Users Meeting to learn about our latest innovative
technologies introduced at ASMS 2010, including the new Xevo™ high performance Benchtop
MS Instruments based upon the Engineered Simplicity™ design approach with a unique workflow
software solution for each application field.
The agenda will run on five parallel tracks focusing on: Biopharmaceutical, Clinical, Food &
Environmental, Proteomics, and Pharmaceuticals.
This event will explore how innovative technologies and applications can increase your productivity
and efficiency, including:
• Stepwave™ technology for ultra high sensitivity MRM,
• meeting the sensitivity challenges of dry blood spot analysis,
• accurate mass for the qualitative and quantitative approach,
• screening for residues; one UPLC®-MS dataset for the targeted and untargeted approach.
This meeting will give you the opportunity to talk to your colleagues and other experts, sharing
opinions, experiences and ideas.
Feel free to forward this invitation to interested colleagues. Seats are limited though, so please
register at www.waters.com/msdays now! We look forward to meeting you at one of our venues.
Mike van Oosterhout
Strategic Markets Manager
Waters Corporation
© 2010 Waters Corporation. Waters, Xevo, Engineered Simplicity, Stepwave, UPLC and The Science of What’s Possible are trademarks of Waters Corporation.
FRANKFURT, GERMANY
THURSDAY OCTOBER 14, 2010
09:00 Registration
09:30 Stepwave™: Ultra High Sensitivity MRM on the Xevo™ TQ-S
David Little, Director - MS Product Management, Waters Corporation
10:00 Addressing the Sensitivity Challenges of Dry Blood Spot Analysis
Jing Lin, Pharmaceutical Marketing Team Manager, Europe & India, Waters Corporation
10:30 Coffee Break
10:45 Accurate Mass for the Quantitative and Qualitative Approach
enabled by Quantof™ Technology on the Xevo G2 QTof™
Mark McDowall, Strategic Development Manager, Waters Corporation
11:15 Residue Screening and Unknown Compound Discovery using MS E enabled UPLC®/QTof
Timothy Jenkins, Business Operations Manager, Waters Corporation
11:45 Additional Innovations in Mass Spectrometry… and Related Techniques 2010
Mark McDowall, Strategic Development Manager, Waters Corporation
12:15 Lunch
13:30 Parallel Tracks PRESENTATIONS #1 *
13:55 Parallel Tracks PRESENTATIONS #2 *
14:20 Coffee Break
14:45 Parallel Tracks PRESENTATIONS #3 *
15:10 Parallel Tracks PRESENTATIONS #4 *
15:35 Parallel Tracks PRESENTATIONS #5 *
16:00 Closing Drinks
This event is FREE to attend. Accommodation and transportation to/from the hotel is the responsibility of
the participant. Nonetheless, accommodation can be provided for 99 Euros. This fee includes dinner with our
experts on October 13 and one night hotel with breakfast at the Mercure Hotel in Eschborn where the event
is held. Would you like to benefit this special offer, please refer to “MSDayEschborn” in your order.
* See details on backpage.
© 2010 Waters Corporation. Waters, Stepwave, Xevo, QuanTof, QTof, UPLC and The Science of What’s Possible are trademarks of Waters Corporation.
WAT ERS MS T ECHNOLOGY DAYS PARALLEL T RACKS
FRANKFURT, GERMANY — THURSDAY OCTOBER 14, 2010
BIOPHARMACEUTICAL
13:30 Biopharmaceutical Analysis
and the Waters Solutions
Dr. Alexander Muck
Biopharmaceutical
Specialist,
Waters Corporation
CLINICAL
FOOD & ENVIRONMENTAL
PROT EOMICS
PHARMACEUTICAL
Significance of 1,25
Dihydroxy Vitamin D
in Diagnostics
Dr. Rupert Schreiner
Labor Dr. Limbach &
Kollegen,
Heidelberg
Analysis of Pesticides
and Pharmaceutical
Residues in Animal
Products
Dr. Jens Lütjohann
Galab Laboratories GmbH,
Geesthacht
A Post Translational
Modified Protein as
Biomarker for the
Caucasian Form of
Moyamoya Disease
Dr. Thomas Franz
MPI für Biologie des
Alterns, Köln
Metabolite Identification
with MS E and MetaboLynx™
Dr. Jochen Schmidt
Abbott Products GmbH,
Hannover
Extra: Innovations in
Metabolite Profiling
Employing Ion-Mobility
Mass Spectrometry and
Novel Fragmentation
Techniques
Speaker to be confirmed
13:55
Characterization of an
Antibody by use of MS E
with a QTof MS Instrument
Dr. Thomas Flad
PANATecs GmbH, Tübingen
Monitoring the Complete
Kynurenine and Serotonin
Pathways of Tryptophan
Metabolism in Vivo and
in Vitro by LC/MS/MS
using Xevo™-TQ
Priv. Doz. Dr. Markus J.
Schwarz, Klinikum der
Universität München, Klinik
und Poliklinik für Psychiatrie
und Psychotherapie
Stepwave™ Technology
Providing the Sensitivity
to Take the Next Step
in Regulatory Food and
Environmental Analysis
David Little
Director - MS Product
Management,
Waters Corporation
Dispersive Analytical
Strategies for Quantitative
and Qualitative Profiling of
complex Protein Mixtures
(Part I)
Mark McDowall
Strategic Development
Manager,
Waters Corporation
14:45
HCP Analysis and HDX
Das Waters ACQUITY
Applications in Biopharma UPLC® TQD System in der
Forensisch-Toxikologischen
Scott Berger
Diagnostik
Marketing Development
Dr. Nadulski
Manager,
Labor Dr. Med. Krone &
Waters Corporation
Partner,
Bad Salzufflen
Direktinjektion und
Probenvorbereitung - ein
Widerspruch?
Dr. Claus Schlett
Westfälische Wasser- und
Umweltanlytik GmbH,
Gelsenkirchen
Non-Targeted Metabolomics
Dispersive Analytical
Platform for de-Novo
Strategies for Quantitative
Biomarker Discovery in
and Qualitative Profiling of
Environmental Health
Complex Protein Mixtures
(Part II)
Dr. Schmitt-Kopplin
German Research Center
Mark McDowall
for Environmental Health
Strategic Development
Manager,
Waters Corporation
15:10
MS Methods for
the Characterisation
of Antibodies
Hr. Dr. Ingo Lindner
Roche Diagnostics GmbH,
Penzberg
Systematic Toxicological Novel Applications of APGC Analysis of Non-covalent
Screening using High
Protein/Ligand Complexes
Technology in Food and
Resolution Q-Tof
on an Orthogonal
Environmental Analysis
Technology and POSI±IVE
Quadrupole TOF (SYNAPT™
Timothy Jenkins
Software
G1) Mass Spectrometer
Business Operations
Peter Batjoens
Dr. Ales Svatos
Manager,
Clinical Specialist,
MPI für Chemische
Waters Corporation
Waters Corporation
Ökologie, Jena
15:35
ETD and HDMS E
...Enabling Technologies
for Biopharma
Mark McDowall
Strategic Development
Manager,
Waters Corporation
Entwicklung Einer UPLC®/
MS/MS Methode zur
Bestimmung von Steroide
in Klinischen ProbenErgebnisse, Vorteile und
Probleme
Dr. Alexandra Kulle
Christian-AlbrechtsUniversität zu Kiel, Allg.
Pädiatrie, Kinderklinik
Lipidomics: Development of
a Lipidomic Platform Based
on a Hybrid Quadrupole
Time-of-Flight (QTof) IonMobility Mass Spectrometer
for both Targeted and nonTargeted Analysis
Speaker to be confirmed
Metabolische Analytik
Standardisation of
Polyfluorierte
Dr. Mark Stahl
Allergenproducts:
Verbindungen (PFT) in der
Absolute Quantification of Eberhardt-Karls-Universität
Umwelt
Tübingen, Zentrum für
Isoallergens by LC/MS E
Dr. Thorsten Stahl
Dr. Andreas Reuter
Molekularbiologie der
Landesbetrieb Hessisches
Paul Ehrlich Institut,
Pflanzen
Landeslabor,
Langen
Wiesbaden
© 2010 Waters Corporation. Waters, MetaboLynx, Xevo, Stepwave, ACQUITY UPLC, UPLC, SYNAPT and The Science of What’s Possible are trademarks of Waters Corporation.
Other trademarks are property of their respective owners.